LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,128,000 | +25.1% | 36,330 | +29.7% | 0.03% | +43.5% |
| Q2 2022 | $2,500,000 | -53.5% | 28,016 | -41.4% | 0.02% | -28.1% |
| Q1 2022 | $5,379,000 | -4.9% | 47,820 | +30.5% | 0.03% | +6.7% |
| Q4 2021 | $5,658,000 | +78.4% | 36,633 | +60.9% | 0.03% | +36.4% |
| Q3 2021 | $3,172,000 | +14.6% | 22,766 | +7.9% | 0.02% | +29.4% |
| Q2 2021 | $2,768,000 | -10.2% | 21,101 | +4.4% | 0.02% | -19.0% |
| Q1 2021 | $3,082,000 | +208.5% | 20,217 | +101.3% | 0.02% | +110.0% |
| Q4 2020 | $999,000 | -46.2% | 10,041 | -48.5% | 0.01% | -54.5% |
| Q3 2020 | $1,858,000 | +75.0% | 19,497 | +105.4% | 0.02% | +46.7% |
| Q2 2020 | $1,062,000 | +236.1% | 9,493 | +118.2% | 0.02% | +15.4% |
| Q1 2020 | $316,000 | -91.8% | 4,351 | -88.2% | 0.01% | -78.0% |
| Q4 2019 | $3,859,000 | -41.7% | 36,999 | -44.4% | 0.06% | -43.3% |
| Q3 2019 | $6,622,000 | +20.0% | 66,528 | +37.6% | 0.10% | +7.2% |
| Q2 2019 | $5,520,000 | -6.2% | 48,357 | +3.3% | 0.10% | +2.1% |
| Q1 2019 | $5,885,000 | – | 46,817 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |